Akers Bio logo
Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00 ET | Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Bio logo
Akers Biosciences Announces a Change to the Board of Directors
May 29, 2018 07:00 ET | Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Bio logo
Akers Biosciences Reports Earnings for Fiscal Year 2017
April 03, 2018 07:03 ET | Akers Biosciences Inc
Total Revenue Up 33% THOROFARE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health...
Akers Bio logo
Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
March 28, 2018 11:20 ET | Akers Biosciences Inc
THOROFARE, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...